Formosa Optical Technology Co.,Ltd. (TPEX:5312)
101.00
+0.50 (0.50%)
Dec 31, 2025, 2:31 PM CST
TPEX:5312 Market Cap
TPEX:5312 has a market cap or net worth of 6.07 billion as of December 31, 2025. Its market cap has decreased by -10.22% in one year.
Market Cap
6.07B
Enterprise Value
6.49B
Revenue
3.98B
Ranking
n/a
PE Ratio
14.57
Stock Price
101.00
Market Cap Chart
Since April 28, 2006, TPEX:5312's market cap has increased from 1.52B to 6.07B, an increase of 300.34%. That is a compound annual growth rate of 7.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 6.07B | -7.34% |
| Dec 31, 2024 | 6.55B | 30.23% |
| Dec 29, 2023 | 5.03B | 44.31% |
| Dec 30, 2022 | 3.48B | -2.68% |
| Dec 30, 2021 | 3.58B | 0.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.42B |
| Bora Pharmaceuticals Co., LTD. | 60.90B |
| Lin BioScience | 33.13B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 31.06B |